Newsletter | April 7, 2020

04.07.20 -- FDA Continues To Accelerate Development Of Novel Therapies For COVID-19

 
Industry Insights
4 Ways To Avoid Failure In Phase III Clinical Manufacturing
Article | By Sylvia Tsengouras, Isabelle Lafosse, and Kara Faford, Thermo Fisher Scientific

Understanding the challenges in the biopharma space is critical, as the planning you do today dictates the options you have later when the costs — and the stakes — get even higher.

Pharmacokinetic Strategies In CNS Drug Discovery
White Paper | GVK Biosciences

Drugs targeting CNS diseases fail regularly. This paper discusses successful PK approaches employed in the recent past, and may help your CNS targeted drug discovery and development efforts.

Expanding SPR Uses In Antibody Effector Function Determination
Webinar | GE Healthcare Life Sciences

In this webinar we demonstrate in order to minimize risk and to get “true” affinity in binding analysis we have adopted the latest innovation in surface plasmon resonance, SPR, technology, Biacore 8K, to develop and qualify assays for monoclonal antibodies and other therapeutic proteins to ensure all critical quality attributes are set and controlled with accuracy and precision.

Most Popular News
Solutions
Leverage Machine Learning For Faster High Content Analysis
GE Healthcare Life Sciences
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.